ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,430 | +55.2% | 413,704 | +120.1% | 0.00% | +100.0% |
| Q2 2023 | $261,232 | -31.4% | 187,937 | -21.5% | 0.00% | -50.0% |
| Q1 2023 | $380,867 | -78.4% | 239,539 | -15.5% | 0.00% | -80.0% |
| Q4 2022 | $1,766,492 | +74.0% | 283,546 | +87.2% | 0.01% | +42.9% |
| Q3 2022 | $1,015,000 | +24.4% | 151,504 | +580.5% | 0.01% | +16.7% |
| Q3 2019 | $816,000 | +33.6% | 22,262 | +69.5% | 0.01% | +50.0% |
| Q2 2019 | $611,000 | -65.6% | 13,137 | -70.3% | 0.00% | -66.7% |
| Q1 2019 | $1,776,000 | -8.9% | 44,225 | +4.3% | 0.01% | -7.7% |
| Q4 2018 | $1,950,000 | +6.0% | 42,400 | +2.3% | 0.01% | +30.0% |
| Q3 2018 | $1,839,000 | -18.2% | 41,450 | -27.7% | 0.01% | -23.1% |
| Q2 2018 | $2,247,000 | +273.3% | 57,325 | +781.9% | 0.01% | +160.0% |
| Q1 2015 | $602,000 | – | 6,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |